Existing studies have indicated that ITGAM modulates the cardiac immune microenvironment in models of sepsis-induced cardiomyopathy, either suppressing or enhancing inflammatory responses depending on the disease stage (Huang et al., 2024). This evidence concerns the gene ITGAM and cardiomyopathy.